Gram-negative Bacteremia clinical trials at UCSF

1 research study open to eligible people

Gram-negative bacteremia is when harmful gram-negative bacteria enter the blood. UCSF is studying if switching to pills is safe after starting IV antibiotics. UCSF is collecting data on recovery, complications, and hospital time.

Showing trials for

  • Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial

    open to eligible people ages 18 years and up

    The Gram-negative bloodstream infection Oral Antibiotic Therapy trial (The GOAT Trial) is a multi-center, randomized clinical trial that hypothesizes that early transition to oral antibiotic therapy for the treatment of Gram-Negative BloodStream Infection (GN-BSI) is as effective but safer than remaining on intravenous (IV) antibiotic therapy for the duration of treatment.

    San Francisco, California and other locations

Our lead scientists for Gram-negative Bacteremia research studies include .

Last updated: